Boxer Capital as of March 31, 2022
Portfolio Holdings for Boxer Capital
Boxer Capital holds 74 positions in its portfolio as reported in the March 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Mirati Therapeutics | 8.5 | $164M | 2.0M | 82.22 | |
Springworks Therapeutics (SWTX) | 6.0 | $117M | 2.1M | 56.44 | |
Iteos Therapeutics (ITOS) | 5.3 | $103M | 3.2M | 32.18 | |
BeiGene Sponsored Adr | 4.8 | $94M | 500k | 188.60 | |
Revolution Medicines (RVMD) | 4.6 | $89M | 3.5M | 25.51 | |
Relay Therapeutics (RLAY) | 4.1 | $80M | 2.7M | 29.93 | |
Cytokinetics Com New (CYTK) | 4.0 | $77M | 2.1M | 36.81 | |
Pmv Pharmaceuticals (PMVP) | 3.7 | $73M | 3.5M | 20.82 | |
Tyra Biosciences (TYRA) | 3.5 | $69M | 6.4M | 10.70 | |
Apellis Pharmaceuticals (APLS) | 3.4 | $66M | 1.3M | 50.81 | |
Prometheus Biosciences | 3.3 | $65M | 1.7M | 37.76 | |
Spdr Ser Tr S&p Biotech (XBI) | 3.2 | $63M | 700k | 89.88 | |
Tango Therapeutics (TNGX) | 2.7 | $52M | 6.9M | 7.58 | |
Merus N V (MRUS) | 2.6 | $50M | 1.9M | 26.44 | |
Arcus Biosciences Incorporated (RCUS) | 2.3 | $45M | 1.4M | 31.56 | |
Reata Pharmaceuticals Cl A | 2.1 | $41M | 1.2M | 32.76 | |
Sage Therapeutics (SAGE) | 1.9 | $36M | 1.1M | 33.10 | |
Blueprint Medicines (BPMC) | 1.7 | $32M | 507k | 63.88 | |
Iovance Biotherapeutics (IOVA) | 1.7 | $32M | 1.9M | 16.65 | |
Anaptysbio Inc Common (ANAB) | 1.7 | $32M | 1.3M | 24.74 | |
ACADIA Pharmaceuticals (ACAD) | 1.6 | $31M | 1.3M | 24.19 | |
Amylyx Pharmaceuticals (AMLX) | 1.5 | $28M | 2.2M | 12.85 | |
Ideaya Biosciences (IDYA) | 1.3 | $25M | 2.2M | 11.19 | |
Rocket Pharmaceuticals (RCKT) | 1.2 | $23M | 1.5M | 15.86 | |
Nuvation Bio Com Cl A (NUVB) | 1.2 | $23M | 4.3M | 5.26 | |
Amicus Therapeutics (FOLD) | 1.1 | $22M | 2.3M | 9.47 | |
Bellus Health Com New | 1.1 | $22M | 3.2M | 6.88 | |
Gossamer Bio (GOSS) | 1.1 | $21M | 2.5M | 8.68 | |
Kinnate Biopharma | 1.1 | $21M | 1.8M | 11.26 | |
Avidity Biosciences Ord (RNA) | 1.1 | $21M | 1.1M | 18.47 | |
Point Biopharma Global | 1.0 | $20M | 2.5M | 7.97 | |
Fate Therapeutics (FATE) | 1.0 | $19M | 500k | 38.77 | |
GH Research Ordinary Shares (GHRS) | 1.0 | $19M | 1.0M | 18.29 | |
Xenon Pharmaceuticals (XENE) | 0.9 | $18M | 600k | 30.57 | |
Nurix Therapeutics (NRIX) | 0.9 | $17M | 1.2M | 14.01 | |
Nuvalent Inc-a (NUVL) | 0.9 | $17M | 1.2M | 13.89 | |
Ultragenyx Pharmaceutical (RARE) | 0.7 | $15M | 200k | 72.62 | |
Milestone Pharmaceuticals (MIST) | 0.7 | $14M | 2.2M | 6.42 | |
Day One Biopharmaceuticals I (DAWN) | 0.6 | $12M | 1.2M | 9.92 | |
Akero Therapeutics (AKRO) | 0.6 | $12M | 832k | 14.19 | |
Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.6 | $11M | 1.3M | 9.01 | |
Cullinan Oncology (CGEM) | 0.6 | $11M | 1.1M | 10.47 | |
Prothena Corp SHS (PRTA) | 0.6 | $11M | 300k | 36.57 | |
Turning Point Therapeutics I | 0.6 | $11M | 400k | 26.85 | |
Theseus Pharmaceuticals | 0.5 | $10M | 892k | 11.53 | |
2Seventy Bio Common Stock (TSVT) | 0.4 | $7.8M | 460k | 17.06 | |
Ngm Biopharmaceuticals | 0.4 | $7.6M | 500k | 15.25 | |
Atreca Cl A Com (BCEL) | 0.4 | $7.0M | 2.2M | 3.17 | |
Solid Biosciences | 0.3 | $6.4M | 5.3M | 1.20 | |
Rain Therapeutics | 0.3 | $6.0M | 1.2M | 5.07 | |
Oric Pharmaceuticals (ORIC) | 0.3 | $5.6M | 1.1M | 5.34 | |
Black Diamond Therapeutics (BDTX) | 0.3 | $5.6M | 2.0M | 2.77 | |
Odonate Therapeutics Ord | 0.3 | $5.6M | 4.2M | 1.32 | |
Codiak Biosciences | 0.3 | $5.3M | 850k | 6.27 | |
Biomea Fusion (BMEA) | 0.3 | $5.3M | 1.2M | 4.46 | |
BCLS Acquisition Corp Com Cl A | 0.3 | $4.9M | 500k | 9.87 | |
Panacea Acquisition Corp II Cl A Shs | 0.3 | $4.9M | 500k | 9.75 | |
Essa Pharma Com New (EPIX) | 0.2 | $4.5M | 725k | 6.19 | |
Eqrx | 0.2 | $4.1M | 1.0M | 4.13 | |
Selecta Biosciences | 0.2 | $4.0M | 3.3M | 1.23 | |
Health Sciences Acq Corp II Ord Shs | 0.2 | $4.0M | 400k | 9.91 | |
Bioatla (BCAB) | 0.2 | $3.5M | 686k | 5.03 | |
DBV Technologies SA Sponsored Adr | 0.2 | $3.4M | 2.1M | 1.59 | |
Aligos Therapeutics | 0.2 | $3.3M | 1.5M | 2.15 | |
Elevation Oncology (ELEV) | 0.1 | $2.2M | 873k | 2.52 | |
Omega Alpha SPAC Cl A | 0.1 | $2.0M | 200k | 9.82 | |
Gemini Therapeutics | 0.1 | $1.8M | 1.3M | 1.39 | |
MEI Pharma Com New | 0.1 | $1.8M | 2.9M | 0.60 | |
Genocea Biosciences Com New (GNCAQ) | 0.1 | $1.4M | 1.1M | 1.25 | |
Cabaletta Bio (CABA) | 0.1 | $1.1M | 540k | 2.03 | |
Protara Therapeutics Com Stk (TARA) | 0.1 | $1.1M | 209k | 5.11 | |
Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.0 | $203k | 267k | 0.76 | |
Bellicum Pharmaceuticals Com New | 0.0 | $123k | 57k | 2.16 | |
Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $17k | 67k | 0.26 |